v3.22.1

Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Income Statement [Abstract]
Revenue	$ 21,575	$ 24,328
Cost of sales	7,690	8,455
Gross profit	13,885	15,873
Operating expenses:
Selling, general and administrative	28,028	28,077
Research and development	9,395	6,370
Loss on assets held for sale	3,136	0
Total operating expenses	40,559	34,447
Loss from operations	(26,674)	(18,574)
Interest expense	(2,054)	(1,375)
Other income (expense), net	(76)	(504)
Loss before income taxes	(28,804)	(20,453)
Income tax (benefit)	0	(422)
Net loss	(28,804)	(20,031)
Other comprehensive income (loss):
Unrealized gain (loss) on short-term investments, net	(43)	14
Comprehensive loss	$ (28,847)	$ (20,017)
Net loss per share, basic (in usd per share)	$ (0.85)	$ (0.61)
Net loss per share, diluted (in usd per share)	$ (0.85)	$ (0.61)
Weighted average common shares used to compute net loss per share, basic (in usd per share)	33,735	33,022
Weighted average common shares used to compute net loss per share, diluted (in usd per share)	33,735	33,022

Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(22))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(24))
-URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(26))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580

Intersect ENT, Inc. 10-Q